At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

Last updated: May 16, 2020
Sponsor: ProofPilot
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Coronavirus

Treatment

N/A

Clinical Study ID

NCT04393961
2458
  • Ages 18-100
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Reside and Currently in New York City

  • Does not have a blood clotting disease

  • Is not abnormally queasy about taking a blood sample

  • Not on any blood thinning medications

  • Able to consent

  • Willingness to take a blood sample

  • Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered

Study Design

Total Participants: 600
Study Start date:
April 05, 2020
Estimated Completion Date:
August 29, 2020

Connect with a study center

  • ProofPilot Online App (https://p.proofpilot.com)

    New York, New York 10003
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.